Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy — Cecilia Covajes (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy
Shared by
Jean Louis Vincent
Université Libre de Bruxelles
Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy
Article
2011
en
Authors
+5 more
CC
Cecilia Covajes
DB
Daniel De Backer
EO
Eva Ocampos-Martinez
Abstract
1 min read
info:eu-repo/semantics/published
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
High Regimen of Continuous Infusion of Vancomycin During Continuous Renal Replacement Therapy
Marjorie Beumier
,
Hakim Kabtouri
,
Frédéric Cotton
,
Maya Hites
,
Jean Louis Vincent
,
Frédérique Jacobs
,
Fabio Taccone
Article
2010
Nephrotoxicity during continuous infusion of vancomycin in septic patient
S Cianferroni
,
A Deviglii
,
Jean‐Michel Hougardy
,
Laura Penaccini
,
Eva Ocampos-Martinez
,
Frédérique Jacobs
,
Jean Louis Vincent
,
Fabio Taccone
Article
2008
Do Recommended Doses of β-lactams in ICU Patients on Continuous Renal Replacement Therapy (CRRT) Reach Therapeutic Concentrations ?
Lucie Seyler
,
Frédéric Cotton
,
Fabio Taccone
,
Pascale Macours
,
Daniel De Backer
,
Z. Kipouros
,
Jean Louis Vincent
,
Frédérique Jacobs
Article
2013
Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy
Cecilia Covajes
,
Sabino Scolletta
,
Laura Penaccini
,
Eva Ocampos-Martinez
,
Ali Abdelhadii
,
Marjorie Beumier
,
Frédérique Jacobs
,
Daniel De Backer
,
Jean Louis Vincent
,
Fabio Silvio Taccone
Article
1998
Consensus Conference: Resuscitation of patients in septic shock
Vladimír Kvetan
,
KY Lak
,
Akiva Leibowitz
,
Ng Ks
,
Kiyoki Okada
,
Tang Gj
,
L. G. Thijs
,
Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.